Bailard »

Artiva Biotherapeutics shares owned by Bailard

Quarter-by-quarter ownership of Artiva Biotherapeutics (ARTV) shares owned by Bailard from 13F filings

Historical chart of Bailard investment in Artiva Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Artiva Biotherapeutics held by Bailard consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Artiva Biotherapeutics by Bailard

Quarter filed Position value Share count Share price at filing
2026-03-31 $133k 21k 6.44

More positions owned by Bailard

Apple (AAPL)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Msci Eafe Etf (EFA)
Gilead Sciences (GILD)
Spdr Series Trust State Street Spd (BIL)
Vanguard World Inf Tech Etf (VGT)
J P Morgan Exchange Traded F Mortgage Backed (JMTG)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Calif Mun Bd Etf (CMF)
Vanguard Index Fds Total Stk Mkt (VTI)
Amazon (AMZN)

View all positions for Bailard

Top funds holding Artiva Biotherapeutics

RA Capital Management
5AM Venture Management
VR Adviser
venBio Partners
Franklin Resources
Revelation Capital Management
Vanguard Group
BlackRock
Vanguard Capital Management
Wellington Management Company
Propel Bio Management
Millennium Management
Renaissance Technologies
Two Sigma Investments
Geode Capital Management

View all funds holding Artiva Biotherapeutics